Aprotinin Used In Heart Surgery Associated With Increased Risk Of Death, Study Shows
Thursday, May 15, 2008 - 22:21
in Health & Medicine
Aprotinin is associated with a 50 percent increase in the relative risk of death, according to a major Canadian clinical trial comparing three drugs routinely used to prevent blood loss during heart surgery. The trial shows that approximately six per cent of patients who received aprotinin died within 30 days of surgery compared to four per cent of patients who received tranexamic acid or aminocaproic acid.
Read the whole article on Science Daily
More from Science Daily
Related
- Aprotinin associated with increased risk of deathWed, 14 May 2008, 13:35:51 EDT
- Risk of death may be higher with drug commonly used during cardiac surgeryTue, 2 Dec 2008, 13:15:55 EST
- Treatment with folic acid, vitamin B12 associated with increased risk of cancer, deathTue, 17 Nov 2009, 19:00:58 EST
- Death rates same for diabetes and heart disease patients receiving drug therapy or surgerySun, 7 Jun 2009, 17:49:18 EDT
- Surgery to reshape ventricle in heart failure patients offers no added benefit over bypassMon, 30 Mar 2009, 10:36:40 EDT